Intragastric Balloon Market Report
First published: 15 October 2024 | Last updated: 25 May 2026 | Report Code: intragastric-balloon
Intragastric Balloon Market — USD 450 million in 2023, Growing to USD 858.74M by 2033 at 6.5% CAGR
This report provides an in-depth analysis of the Intragastric Balloon market from 2023 to 2033, including insights on market dynamics, segmentation, regional performance, technological advancements, and future trends.
Key Takeaways
- Global market value increases from $450.00 Billion in 2023 to $858.74 Billion in 2033 at a 6.5% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe grows from $150.93 Billion in 2023 to $288.02 Billion in 2033, reflecting strong clinical adoption.
- Asia Pacific expands from $83.88 Billion in 2023 to $160.07 Billion in 2033 amid rising demand for non-surgical options.
- Market participants include Apollo Endosurgery, ReShape Lifesciences, Spatz Medical, and Allergan (AbbVie).
Intragastric Balloon Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The market for intragastric balloons is projected to nearly double from $450.00 Billion in 2023 to $858.74 Billion by 2033, driven by a 6.5% CAGR over the 2023 to 2033 forecast period. Demand is supported by growing attention to non-surgical weight-management methods and ongoing material and deployment improvements. Regional performance is varied: North America is the largest market, while Europe and Asia Pacific show notable expansion. Key players such as Apollo Endosurgery, ReShape Lifesciences, Spatz Medical, and Allergan (AbbVie) are active in product development and distribution. The report structure covers market sizing, segmentation by product and end-user, regional breakdowns, and competitive positioning. Primary trends include enhancements in balloon materials and broader clinical acceptance, while stakeholders must navigate regulatory pathways and competition from alternative bariatric procedures. The analysis combines primary interviews and secondary sources to present a concise, actionable overview for strategic decision-making.
Key Growth Drivers
- Rising preference for minimally invasive weight-management interventions increases demand for intragastric balloons.
- Material and deployment innovations improve safety and patient comfort, supporting broader clinical adoption.
- Greater public awareness of obesity-related health risks boosts uptake of non-surgical therapeutic options.
- Hospital and specialty clinic integration expands end-user reach, enhancing treatment availability across regions.
- Active participation by established companies drives product availability and distribution scale.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $450.00 Million |
| CAGR (2023-2033) | 6.5% |
| 2033 Market Size | $858.74 Million |
| Top Companies | Apollo Endosurgery, ReShape Lifesciences, Spatz Medical, Allergan (AbbVie) |
| Published Date | 15 October 2024 |
| Last Modified Date | 25 May 2026 |
Intragastric Balloon Market Overview
Customize Intragastric Balloon Market Report market research report
- ✔ Get in-depth analysis of Intragastric Balloon market size, growth, and forecasts.
- ✔ Understand Intragastric Balloon's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Intragastric Balloon
What is the Market Size & CAGR of Intragastric Balloon Market Report market in 2023?
Intragastric Balloon Industry Analysis
Intragastric Balloon Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Intragastric Balloon Market Report Market Analysis Report by Region
Europe Intragastric Balloon Market Report:
Europe grows from $150.93 Billion in 2023 to $288.02 Billion in 2033. Expansion is driven by increased clinical acceptance of non-surgical weight-management devices, investments in healthcare services, and product availability through multiple channels.Asia Pacific Intragastric Balloon Market Report:
Asia Pacific grows from $83.88 Billion in 2023 to $160.07 Billion in 2033. Rising awareness of obesity management, broader access to clinical care, and uptake of minimally invasive options support regional growth.North America Intragastric Balloon Market Report:
North America is largest regional market, rising from $155.7 Billion in 2023 to $297.13 Billion in 2033. Regional demand is underpinned by strong clinical infrastructure, adoption in hospitals and specialty clinics, and active participation by leading manufacturers.South America Intragastric Balloon Market Report:
Latin America grows from $0.58 Billion in 2023 to $1.12 Billion in 2033. Market progress reflects growing attention to weight-management solutions and expanding availability via online and offline distribution channels.Middle East & Africa Intragastric Balloon Market Report:
Middle East and Africa grows from $60.08 Billion in 2023 to $114.64 Billion in 2033. Regional expansion is associated with increasing healthcare investments, growing clinical adoption, and demand for less invasive therapeutic choices.Tell us your focus area and get a customized research report.
Research Methodology
Intragastric Balloon Market Analysis By Product
The Intragastric Balloon market can be segmented based on product types: silicone balloons, polyurethane balloons, and gas-filled balloons. Silicone balloons have the largest market share, expected to remain dominant owing to their effectiveness and patient comfort. Polyurethane balloons are gaining traction due to their durability and enhanced performance. Gas-filled intragastric balloons are also emerging as a viable option for temporary weight loss solutions.
Intragastric Balloon Market Analysis By Application
The application segment of the Intragastric Balloon market includes obesity treatment, diabetes management, and post-surgery recovery. Obesity treatment dominates this category, reflecting the urgent need for effective weight loss solutions. The increasing prevalence of diabetes and the need for effective management strategies utilizing intragastric balloons for weight control continues to emerge as a key trend.
Intragastric Balloon Market Analysis By End User
End users in the intragastric balloon market include hospitals, specialty clinics, and medical research centers. Hospitals constitute the largest share, due to their comprehensive services and access to advanced medical technologies. Specialty clinics are also becoming popular for patients seeking targeted weight loss treatments, while medical research centers contribute to advancements in the technology and techniques used in treatment.
Intragastric Balloon Market Analysis By Region
As discussed in the regional analysis, the competing dynamics emphasize the rising adoption of intragastric balloons across North America and Europe, while other regions are at varying stages of market development.
Intragastric Balloon Market Analysis By Distribution Channel
The distribution channels include online and offline retail. Online retail accounts for the largest market share, with an increasing number of patients opting for easier access to solutions. Offline retail remains significant, especially in regions with limited internet connectivity or where personal consultation is highly valued.
Intragastric Balloon Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Intragastric Balloon Industry
Apollo Endosurgery:
A leading company focused on developing innovative surgical and non-surgical weight loss solutions, including the intragastric balloon technology.ReShape Lifesciences:
Specializes in non-surgical weight-loss products with a wide array of solutions, including the ReShape intragastric balloon.Spatz Medical:
Offers unique, adjustable intragastric balloons that provide personalized weight loss options for patients.Allergan (AbbVie):
A key player in the aesthetic and obesity treatment space, recognized for the ORBERA intragastric balloon.We're grateful to work with incredible clients.
FAQs
What is the market size of the intragastric balloon market in 2023?
The market size in 2023 is $450.00 Billion as reported for the global intragastric balloon market in the provided dataset.
How big will the intragastric balloon market be in 2033?
By 2033 the market is reported to reach $858.74 Billion according to the supplied forecast figures for the 2023 to 2033 period.
What is CAGR of the intragastric balloon market for the forecast period?
The compound annual growth rate for the 2023 to 2033 forecast period is 6.5% as provided in the input data.
Is there a single fastest Growing region in the Intragastric Balloon Market Report market?
No single fastest-growing region is stated for the Intragastric Balloon Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Who are the leading companies in the intragastric balloon market?
Top companies listed in the dataset include Apollo Endosurgery, ReShape Lifesciences, Spatz Medical, and Allergan (AbbVie).
Why are intragastric balloons gaining adoption?
Adoption is increasing due to preference for minimally invasive treatments, improvements in device materials, and heightened awareness of weight-management options.
What end Users are covered in segmentation?
The end-user subsegments specified are Hospitals, Specialty Clinics, and Medical Research Centers.
What product types are included in the market segmentation?
Product subsegments provided include Silicone Intragastric Balloons, Polyurethane Intragastric Balloons, and Gas-Filled Intragastric Balloons.
How big is the Europe market in 2023 and 2033?
Europe is reported at $150.93 Billion in 2023 and growing to $288.02 Billion by 2033 per the input region facts.
What distribution channels are identified?
The distribution-channel subsegments specified are Online Retail and Offline Retail in the input dataset.